Top compounds associated with response to RSAD2


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan CCLE pan-cancer AAC -0.11 0.04
mRNA FK866 GDSC1000 pan-cancer AAC -0.062 0.04
mRNA ML083 CTRPv2 pan-cancer AAC 0.077 0.04
mRNA TAE684 GDSC1000 pan-cancer AAC 0.1 0.04
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.16 0.04
mRNA AZD-2281 FIMM pan-cancer AAC 0.35 0.04
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.068 0.05
mRNA Nutlin-3 CCLE pan-cancer AAC -0.093 0.05
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.075 0.05
mRNA Rapamycin gCSI pan-cancer AAC -0.11 0.05
Download CSV